Literature DB >> 26574899

Microarray expression profiling of dysregulated long non-coding RNAs in Hirschsprung's disease reveals their potential role in molecular diagnosis.

Z Shen1,2, C Du1,2, R Zang1,2, H Xie1,2, W Lv3, H Li1,2, Y Xia1,4, W Tang1,2.   

Abstract

BACKGROUND: Hirschsprung's disease (HSCR) is one of the common digestive disorders in the new born. Long non-coding RNAs (lncRNAs) play an important role in various biological processes. However, knowledge on lncRNAs in HSCR is limited.
METHODS: The expression profile of lncRNAs in HSCR was obtained using microarray. A total of 2078 differentially expressed lncRNAs were detected by microarray in HSCR tissues compared with matched normal colon tissues (fold change ≥2, p < 0.05). Candidate biomarkers were selected from these differentially expressed lncRNAs based on artificial criterion (raw signal intensity ≥50; fold change ≥8) and then validated in 80 pairs of HSCR and normal tissues using quantitative real-time polymerase chain reaction (qRT-PCR). Moreover, the computational analysis was used to evaluate the lncRNA-microRNA and lncRNA-protein relationships. KEY
RESULTS: A panel of 5-lncRNAs was identified to distinguish HSCR from normal tissues with remarkable sensitivity and specificity. The area under the receiver operating characteristic curve (AUC) for HSCR identification in the validation set was 0.875. The bioinformatics analysis reveals that these dysregulated lncRNAs are mainly involved in RNA-protein relationships, including RNA splicing, binding, transport, processing, and localization. CONCLUSIONS & INFERENCES: Our results are the first to report the expression profile of dysregulated lncRNAs in HSCR and infer that lncRNAs may serve as novel diagnostic biomarkers for HSCR.
© 2015 John Wiley & Sons Ltd.

Entities:  

Keywords:  HSCR; LncRNA; microarray; molecular diagnosis

Mesh:

Substances:

Year:  2015        PMID: 26574899     DOI: 10.1111/nmo.12722

Source DB:  PubMed          Journal:  Neurogastroenterol Motil        ISSN: 1350-1925            Impact factor:   3.598


  7 in total

1.  Long non-coding RNA LOC100507600 functions as a competitive endogenous RNA to regulate BMI1 expression by sponging miR128-1-3p in Hirschsprung's disease.

Authors:  Yang Su; Zechao Wen; Qiyang Shen; Hua Zhang; Lei Peng; Guanglin Chen; Zhongxian Zhu; Chunxia Du; Hua Xie; Hongxing Li; Yankai Xia; Weibing Tang
Journal:  Cell Cycle       Date:  2018-02-12       Impact factor: 4.534

2.  Hirschsprung's disease: key microRNAs and target genes.

Authors:  Mei Hong; Xiangyang Li; Yuan Li; Yun Zhou; Yibo Li; Shuiqing Chi; Guoqing Cao; Shuai Li; Shaotao Tang
Journal:  Pediatr Res       Date:  2021-12-09       Impact factor: 3.953

3.  Apoptotic neuron-secreted HN12 inhibits cell apoptosis in Hirschsprung's disease.

Authors:  Chunxia Du; Hua Xie; Rujin Zang; Ziyang Shen; Hongxing Li; Pingfa Chen; Xiaoqun Xu; Yankai Xia; Weibing Tang
Journal:  Int J Nanomedicine       Date:  2016-11-07

4.  Circular RNA ZNF609 functions as a competitive endogenous RNA to regulate AKT3 expression by sponging miR-150-5p in Hirschsprung's disease.

Authors:  Lei Peng; Guanglin Chen; Zhongxian Zhu; Ziyang Shen; Chunxia Du; Rujin Zang; Yang Su; Hua Xie; Hongxing Li; Xiaoqun Xu; Yankai Xia; Weibing Tang
Journal:  Oncotarget       Date:  2017-01-03

5.  Genome-wide analysis of long non-coding RNAs in esophageal squamous cell carcinoma reveals their potential role in invasion and metastasis.

Authors:  Jihua Wang; Dianshui Sun; Kai Wu; Jie Liu; Miaoqing Zhao; Xiaomei Li; Ying Xu; Baosheng Li
Journal:  Thorac Cancer       Date:  2018-11-03       Impact factor: 3.500

6.  Negative Association Between lncRNA HOTTIP rs3807598 C>G and Hirschsprung Disease.

Authors:  Yi Zheng; Zhenjian Zhuo; Xiaoli Xie; Lifeng Lu; Qiuming He; Wei Zhong
Journal:  Pharmgenomics Pers Med       Date:  2020-05-06

7.  LncRNA-RMST Functions as a Transcriptional Co-regulator of SOX2 to Regulate miR-1251 in the Progression of Hirschsprung's Disease.

Authors:  Lingling Zhou; Zhengke Zhi; Pingfa Chen; Chunxia Du; Binyu Wang; Xiang Fang; Weibing Tang; Hongxing Li
Journal:  Front Pediatr       Date:  2022-03-07       Impact factor: 3.418

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.